In our study, lymphatic podoplanin deletion and consequential reduction in MSMs did not impact on primary B16F10 tumor growth, which is in contrast to the complete deletion of both MSMs and subcapsular sinus macrophages (SSMs) using CD169-DTR mice that exacerbated primary tumor growth [82]. The gene discussed is PDPN; the disease is neoplasm.